United States Market Report for Orthopedic Bone Graft Substitutes 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Market Report for Orthopedic Bone Graft Substitutes 2017 - MedCore" report to their offering.

As of 2016, the synthetic bone grafts accounted for the largest portion of the market followed by the demineralized bone matrix (DBM) grafts. Market growth has been supported by the strong adoption of the BMP growth factor market, which is represented by Medtronic's INFUSEĀ® product.

Furthermore, the fast-growing cellular allograft market has benefited the bone graft substitute market by allowing greater osteogenic properties with the use of stem cells. The recent resurgence of growth in the cheaper allograft material market has pushed DBM prices lower in order to stay competitive.

The synthetic bone graft segment surpassed the DBM segment due to both a higher ASP and stronger unit sales growth in the U.S. market. Synthetic grafts are more commonly used in spinal surgeries rather than applications involving larger volumes, as with fracture repair. These large volume indications are the reason that cheaper options, such as allograft bone, play an important role in the market.

Key Topics Covered:

1. Research Methodology

2. Disease Overview

2.1 Basic Anatomy

2.1.1 Osteology And Musculoskeletal System

2.2 Disease Pathology And Disorders

2.2.1 General Diagnostic

2.2.2 Osteoporosis

2.2.3 Osteoarthritis

2.2.4 Indication For Bone Graft Procedure

2.2.5 Indication For Cartilage Repair

2.2.6 Degenerative Disc Disease

2.3 Patient Demographics

2.3.1 General Statistics

3. Product Assessment

3.1 Product Portfolios

3.1.1 Bone Graft Substitutes

3.2 Regulatory Issues And Recalls

3.2.1 Bone Graft Substitutes

3.3 Clinical Trials

3.3.1 Bone Graft Substitutes

4. Orthopedic Bone Graft Substitute Market

4.1 Introduction

4.1.1 Units Per Procedure By Indication

4.2 Market Overview

4.2.1 Bone Graft Substitute Market By Material

4.2.2 Bone Graft Substitute Market By Indication

4.3 Market Analysis And Forecast

4.3.1 Total Orthopedic Bone Graft Substitute Market

4.3.2 Bone Graft Substitute Market By Material

4.3.2.1 Total Allograft Bone Graft Substitute Market

4.3.2.2 Allograft Bone Graft Substitute Market By Indication

4.3.2.3 Total Demineralized Bone Matrix Market

4.3.2.4 Demineralized Bone Matrix Market With And Without Carriers

4.3.2.5 Demineralized Bone Matrix Market By Indication

4.3.2.6 Total Synthetic Bone Graft Substitute Market

4.3.2.7 Synthetic Bone Graft Substitute Market By Indication

4.3.3 Bone Graft Substitute Market By Indication

4.3.3.1 Spine

4.3.3.2 Trauma

4.3.3.3 Large Joint Reconstruction

4.3.3.4 Foot Reconstruction

4.3.3.5 Craniomaxillofacial

4.3.3.6 Oncology

4.4 Drivers And Limiters

4.4.1 Market Drivers

4.4.2 Market Limiters

4.5 Competitive Market Share Analysis

Companies Mentioned

  • Medtronic
  • Genzyme
  • DePuy Synthes
  • Anika Therapeutics
  • Ferring Pharmaceuticals
  • Stryker
  • NuVasive
  • Bioventus
  • Zimmer Biomet
  • Integra LifeSciences
  • RTI Surg

For more information about this report visit http://www.researchandmarkets.com/research/tt6fqn/us_market_report

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomaterials

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomaterials